Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11099 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1702 Views
-
Last post by NHE
-
- 0 Replies
- 1352 Views
-
Last post by NHE
-
- 4 Replies
- 1490 Views
-
Last post by NHE
-
- 0 Replies
- 1192 Views
-
Last post by NHE
-
- 0 Replies
- 1480 Views
-
Last post by NHE
-
- 0 Replies
- 1930 Views
-
Last post by frodo
-
- 0 Replies
- 1996 Views
-
Last post by NHE
-
- 0 Replies
- 1562 Views
-
Last post by NHE